December 12, 2019 | Boston Real Estate Times
BOSTON – The Davis Companies announced that Civetta Therapeutics, LLC leased 29,871 square feet of laboratory and office space at The Quad at 10 Wilson Road in Cambridge, MA.
Civetta Therapeutics is a biotechnology company focused on developing therapeutics for cancer and other diseases.
McKenna K. Teague of CBRE represented the tenant, Civetta Therapeutics, and Eric Smith of CBRE represented the landlord, a joint venture between The Davis Companies and Invesco.
The Quad is a ±510,000 RSF life science campus comprising four new and redeveloped life science/lab/R&D buildings. It is located just minutes from Alewife Station, the anchor of the MBTA’s Red Line, connecting the region’s top talent and well-educated work force in West Cambridge with Harvard Square, Kendall Square, Downtown Boston, and the Seaport neighborhood.
“We are thrilled to welcome Civetta Therapeutics to The Quad,” said Duncan Gilkey, head of leasing at The Davis Companies. “With a near zero percent lab vacancy rate in Cambridge’s Kendall Square laboratory arena, we’re seeing growing demand for life science and biotech space in the Alewife area as growing companies like Civetta continue to place importance on access to top industry talent and proximity to its peers. The Quad campus offers added appeal in that we are bringing more Class-A lab inventory online in the upcoming years to sustain future growth.”
“The Quad offers the life science and biotech communities a unique opportunity to expand into a new, urban campus setting in West Cambridge’s innovation cluster,” said Smith. “The Quad encompasses nearly 10 acres of land and with construction nearly complete at 10 Wilson Road, the new campus has positioned itself as a welcome relief valve for rapidly growing life science and biotech companies.”
Civetta was founded by Deerfield Management and scientific leaders William Sellers, MD and Eric Fischer, PhD. Dr. Sellers is a Core Institute Member of the Broad Institute of MIT and Harvard and a Professor of Medicine at the Dana-Farber Cancer Institute and Harvard Medical School. Dr. Fischer is an Assistant Professor in the Department of Biological Chemistry and Molecular Pharmacology at Harvard Medical School and an Independent Investigator at the Dana-Farber Cancer Institute.
“It’s a very exciting time for us. As an emerging company committed to advancing research and new medicines, we were seeking a new research and operational home that would suit our energy and passion while also maintaining close bonds to the biopharma community. 10 Wilson and The Quad will offer existing and new Civetta employees a fresh campus feel that encourages collaboration, ingenuity, and discovery,” said Bruce Goldsmith, PhD, Interim CEO for Civetta Therapeutics.
The Quad (10 Wilson Road, 75 Moulton Street, 101 Smith Place, and 40 Smith Place) is an ideally situated campus, at the intersection of Cambridge and the MetroWest suburbs near Alewife via Route 2, offering tenants a thriving live-work-play dynamic with a wide amenity base nearby. As an added benefit, The Quad also joins over 1,002,180 SF of occupied space filled with similar innovative tenants.
The Quad offers companies an unmatched ecosystem in which to scale their business, along with campus parking and a dedicated shuttle transporting employees to and from the Alewife MBTA Red Line Station. Staying true to the original intent of The Quad design on university campuses, the setting is ripe for interaction surrounded by state-of-the-art lab systems and infrastructures, a community park and café space, fresh landscaping, event programming, and modern offices and meeting rooms. As the newest member of West Cambridge’s life science cluster, The Quad sets itself apart from others by encouraging the blend of workplace and lifestyle to drive curiosity and innovative thinking.
To learn more about the Quad, visit https://thequadcambridge.com/
The Davis Companies Sells Alewife Research Center In Cambridge To HealthPeak For $332.5 Million
December 11, 2019 | Boston Real Estate Times
BOSTON – The Davis Companies announced the sale of the Alewife Research Center , a newly developed Class A laboratory building located at 35 CambridgePark Drive in Cambridge, MA to Healthpeak Properties Inc.
Vice Chairman Edward Maher, Executive Managing Directors Matthew Pullen and James Tribble and Director Samantha Hallowell of Newmark Knight Frank’s (NKF) Boston Capital Markets team – which is led by Co-Head of U.S. Capital Markets Robert Griffin – oversaw the transaction with a reported sale price of $332.5M.
Developed by the Davis Companies in partnership with Invesco and completed in November of 2018, Alewife Research Center (ARC) is a state-of-the-art, 224,305-square-foot life science building with a 331-space parking garage.